Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
28.82
-0.48 (-1.64%)
At close: Feb 13, 2026
SHA:688161 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 1,509 | 1,723 | 1,860 | 2,717 | 2,560 | 1,601 |
Short-Term Investments | - | 1,326 | 1,219 | 1,195 | 1,091 | - |
Trading Asset Securities | 326.27 | 90.54 | - | - | 10 | - |
Cash & Short-Term Investments | 1,835 | 3,140 | 3,080 | 3,912 | 3,660 | 1,601 |
Cash Growth | -8.09% | 1.95% | -21.27% | 6.88% | 128.57% | -11.64% |
Accounts Receivable | 386.68 | 295.74 | 361.99 | 620.13 | 427.29 | 349.96 |
Other Receivables | 1.78 | 14.05 | 2.2 | 2.89 | 1.57 | 9.34 |
Receivables | 388.46 | 309.79 | 364.18 | 623.02 | 428.86 | 359.3 |
Inventory | 610.83 | 686.59 | 753.78 | 666.62 | 564.9 | 555.62 |
Other Current Assets | 1,530 | 54.72 | 66.15 | 47.46 | 44.89 | 32.72 |
Total Current Assets | 4,364 | 4,191 | 4,264 | 5,249 | 4,699 | 2,549 |
Property, Plant & Equipment | 399.93 | 433.16 | 471.22 | 441.56 | 417.46 | 362.83 |
Goodwill | 34.3 | 34.47 | 34.71 | - | - | - |
Other Intangible Assets | 92.06 | 99.74 | 113.78 | 100.56 | 100.05 | 106.5 |
Long-Term Deferred Tax Assets | 82.34 | 79.8 | 81.86 | 64.93 | 64.46 | 56.48 |
Long-Term Deferred Charges | 98.3 | 75.44 | 100.01 | 96.68 | 92.77 | 92.29 |
Other Long-Term Assets | 21.91 | 34.42 | 31.05 | 63 | 29.66 | 7.5 |
Total Assets | 5,093 | 4,948 | 5,097 | 6,016 | 5,403 | 3,175 |
Accounts Payable | 268.22 | 179.45 | 194.59 | 159.68 | 349.19 | 262.88 |
Accrued Expenses | 119.31 | 217.46 | 277.59 | 426.81 | 134.47 | 124.03 |
Current Portion of Leases | 2.15 | 4.89 | 4.72 | 4.49 | 4.88 | - |
Current Income Taxes Payable | 28.33 | 17.83 | 6.9 | 34.31 | 35.06 | 43.42 |
Current Unearned Revenue | 29.17 | 36.61 | 91.98 | 46.11 | 28.09 | 37.8 |
Other Current Liabilities | 429.25 | 402.21 | 510.74 | 217.49 | 181.93 | 142.66 |
Total Current Liabilities | 876.43 | 858.44 | 1,087 | 888.89 | 733.63 | 610.79 |
Long-Term Leases | 0.46 | 1.54 | 5.88 | 9.53 | 12.37 | - |
Long-Term Unearned Revenue | 29.09 | 27.53 | 28.89 | 30.53 | 38.05 | 30.3 |
Long-Term Deferred Tax Liabilities | 10.57 | 10.91 | 13.03 | 10.64 | 11.08 | 8.48 |
Other Long-Term Liabilities | 89.9 | 86.36 | 88.14 | 70.05 | 70.51 | 60.88 |
Total Liabilities | 1,006 | 984.79 | 1,222 | 1,010 | 865.64 | 710.44 |
Common Stock | 400 | 400 | 400 | 400 | 400 | 358.59 |
Additional Paid-In Capital | 1,338 | 1,318 | 1,318 | 2,367 | 2,349 | 1,003 |
Retained Earnings | 2,416 | 2,316 | 2,188 | 2,239 | 1,783 | 1,092 |
Treasury Stock | -80.01 | -80.01 | -36.53 | - | - | - |
Total Common Equity | 4,073 | 3,954 | 3,869 | 5,006 | 4,532 | 2,454 |
Minority Interest | 13.5 | 9.73 | 5.2 | 0.15 | 6.09 | 10.36 |
Shareholders' Equity | 4,087 | 3,963 | 3,874 | 5,006 | 4,538 | 2,464 |
Total Liabilities & Equity | 5,093 | 4,948 | 5,097 | 6,016 | 5,403 | 3,175 |
Total Debt | 2.61 | 6.43 | 10.6 | 14.02 | 17.25 | - |
Net Cash (Debt) | 1,832 | 3,133 | 3,069 | 3,898 | 3,643 | 1,601 |
Net Cash Growth | -7.92% | 2.09% | -21.26% | 7.00% | 127.49% | -11.64% |
Net Cash Per Share | 4.60 | 7.84 | 7.65 | 9.73 | 9.60 | 4.47 |
Filing Date Shares Outstanding | 397.29 | 397.29 | 399.08 | 400 | 400 | 358.59 |
Total Common Shares Outstanding | 397.29 | 397.29 | 399.08 | 400 | 400 | 358.59 |
Working Capital | 3,488 | 3,333 | 3,177 | 4,360 | 3,965 | 1,938 |
Book Value Per Share | 10.25 | 9.95 | 9.69 | 12.51 | 11.33 | 6.84 |
Tangible Book Value | 3,947 | 3,819 | 3,720 | 4,905 | 4,431 | 2,347 |
Tangible Book Value Per Share | 9.93 | 9.61 | 9.32 | 12.26 | 11.08 | 6.55 |
Buildings | - | 313.47 | 318.41 | 254.32 | 254.32 | 254.32 |
Machinery | - | 597.59 | 584.24 | 564.87 | 488.23 | 414.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.